Technology

Non-invasive technology for isolating Rare Circulating Cells

ScreenCell is a simple and innovative technology for isolating Circulating Tumor Cells and potentially any large cell from whole blood or potentially other biological fluids (ascites, urine, pleural and cerebrospinal fluids..)

ScreenCell is a size-based antibody-independent technology applicable to all solid tumors (including melanoma and non-epithelial tumors). ScreenCell also provides easy access to clusters.

Our technology enables a wide range of applications: phenotypical, genotypical, and functional characterization either with fixed or live cells thanks to specific ScreenCell buffers.

HIGHLIGHTS OF THE TECHNOLOGY APPLICATIONS

• Easy-to-use, compact, and single-use device
• Cell size-based isolation device
• Antibody-independent (ex. EpCam independent)
• Ability to work on living and fixed cells
• No instrumentation required
• Fast isolation process <3 min
• High recovery rate
• Technology applicable to all types of solid tumors
• Access to a wide range of technologies for precision medicine
• CTCs can be isolated on glass slides compatible with automatic staining systems.

ScreenCell CYTO and MB Kits are CE-IVD.